Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug?
Heusch
G
G
D015906:Angioplasty, Balloon, Coronary; D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use; D004562:Electrocardiography / Q000187:drug effects; D023381:Endpoint Determination; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D019157:Ischemic Preconditioning, Myocardial; D017202:Myocardial Ischemia / Q000378:metabolism / Q000517:prevention & control / Q000628:therapy*; D009292:Narcotic Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D005996:Nitroglycerin / Q000008:administration & dosage / Q000494:pharmacology*; D015221:Potassium Channels / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D005343:Fibrinolytic Agents; D009292:Narcotic Antagonists; D015221:Potassium Channels; D014665:Vasodilator Agents; D005996:Nitroglycerin